Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Human Monoclonal STXBP1 Primary Antibody for IF, IP - ABIN967910
Fisher, Pevsner, Burgoyne: Control of fusion pore dynamics during exocytosis by Munc18. in Science (New York, N.Y.) 2001
Show all 5 Pubmed References
Human Monoclonal STXBP1 Primary Antibody for IF, IP - ABIN967911
Shuang, Zhang, Fletcher, Groblewski, Pevsner, Stuenkel: Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. in The Journal of biological chemistry 1998
Show all 5 Pubmed References
Chicken Polyclonal STXBP1 Primary Antibody for WB - ABIN2475759
Pevsner, Hsu, Scheller: n-Sec1: a neural-specific syntaxin-binding protein. in Proceedings of the National Academy of Sciences of the United States of America 1994
Show all 3 Pubmed References
Human Polyclonal STXBP1 Primary Antibody for IHC (p), IHC - ABIN188542
Swanson, Steel, Valle: Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release. in Genomics 1998
9q33.3q34.11 microdeletion including STXBP1 gene identified in four patients with intellectual disability, epilepsy, nail (show CD244 Antibodies) dysplasia and bone malformations.
We report the case of a 19-month-old child with Ohtahara syndrome who displays a previously unreported mutation in STXBP1 This mutation is located in a donor splice site and eliminates exon 14, resulting in a truncated protein
We conducted a cohort study to analyze STXBP1 in 42 patients with epileptic encephalopathy. We identified four novel mutations: two splicing mutations, a frameshift mutation, and a nonsense mutation.
Reduced expression of STXBP1 leads to changes in the expression and localization of syntaxin-1 (show STX1A Antibodies) in pluripotent stem cells from epileptic encephalopathy patient.
Seizure severity and intellectual disability were connected to STXBP1 encephalopathy patients.
partial STXBP1 loss of function robustly impairs neurotransmitter release in human neurons, and suggest that heterozygous STXBP1 mutations cause early epileptic encephalopathy specifically through a presynaptic impairment.
The case described suggests a relationship between the Rett syndrome and the STXBP1 gene not described so far, making the search for STXBP1 gene mutations advisable in patients with Rett syndrome and early onset of epilepsy.
A de novo mutation in STXBP1 was detected with exome sequencing together with profound impairment of complex I of the mitochondrial respiratory chain on muscle biopsy. Findings implicate a secondary impairment of mitochondrial function.
Epileptic encephalopathy related to mutations in the STXBP1 genes.
In vitro interaction assays indicated that Doc2b (show DOC2B Antibodies) is required to bridge the interaction between Munc18c (show STXBP3 Antibodies) and Munc18-1 in the macromolecular complex; Munc18c (show STXBP3 Antibodies) and Munc18-1 failed to associate in the absence of Doc2b (show DOC2B Antibodies)
proteins, such as syntaxin-1 (show STX1A Antibodies), Munc18-1, or SNAP-25 (show SNAP25 Antibodies), modulate alpha-synuclein (show SNCA Antibodies) neuropathy and/or are dysregulated in Alzheimer's disease, understanding this type of neurodegeneration may provide new links between synaptic defects and neurodegeneration in humans
This results of study concluded that a conformational change within helix 12 is responsible for the essential postdocking role of Munc18-1 in neurosecretion.
In this studying the Munc18-1-/- nervous system, we demonstrate that synaptic activity is dispensable for the early formation of spinal motor circuits at the levels of axon guidance, differentiation of transcriptional identity, and mRNA expression.
Vamp2 (show VAMP2 Antibodies) mutations that impair Munc18-1 binding inhibit spontaneous as well as evoked neurotransmitter release, providing evidence for the Vamp2 (show VAMP2 Antibodies)-regulating function of Munc18-1 in synaptic exocytosis.
A dynamic PKC (show PKC Antibodies) phosphorylation/de-phosphorylation cycle of Munc18-1 drives short-term enhancement of transmitter release during post-tetanic potentiation.
miR (show MLXIP Antibodies)-218 and miR (show MLXIP Antibodies)-322 directly interact with Stxbp1 by targeting the 3'UTR (show UTS2R Antibodies) of its mRNA.
Munc18-1 levels correlate with synaptic strength.
Syntaxin binding protein 1 is not required for allergic inflammation via IgE-mediated mast cell activation.
[review] Regulation of cortical F-actin is a shared function of Sec1/Munc18-like proteins; a way to gain more insight in the molecular mechanism underlying the Munc18-1-mediated cortical F-actin regulation is proposed.
The N-terminal syntaxin-1 (show STX1A Antibodies) domains mediate different functions in synaptic vesicle fusion, probably via formation of distinct Munc18/SNARE (show VTI1B Antibodies)-protein complexes.
Epilepsy, Behavioral Abnormalities, and Physiological Comorbidities in Syntaxin-Binding Protein 1 (STXBP1) Mutant Zebrafish.
This gene encodes a syntaxin-binding protein. The encoded protein appears to play a role in release of neurotransmitters via regulation of syntaxin, a transmembrane attachment protein receptor. Mutations in this gene have been associated with infantile epileptic encephalopathy-4. Alternatively spliced transcript variants have been described.
syntaxin binding protein 1
, Ras opposite
, syntaxin-binding protein 1-like
, protein unc-18 homolog 1
, protein unc-18 homolog A
, syntaxin-binding protein 1
, unc-18 homolog
, neuronal SEC1
, UNC-18 homolog
, minisatellite 10g detected by probe MMS10
, syntaxin 1-binding protein